Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers
Clinical trial NCT05456490 · COMPLETED
Trial details
- NCT number
- NCT05456490
- Sponsor
- Pacira Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-18
- Primary completion
- 2025-02-27
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.